U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07882576) titled 'A Study to Evaluate Treatment Patterns and Investigate Adult Patients With B-cell Lymphoma' on Sept. 28.
Brief Summary: This is a retrospective observational registry study designed to characterise patient profiles, assess treatment patterns, evaluate clinical outcomes and explore COO testing patterns among adult patients with newly diagnosed LDGCB who have not previously received treatment (TN) and are receiving first-line (1L) treatment.
Study Start Date: Nov. 30
Study Type: OBSERVATIONAL
Condition:
Lymphoma, B-Cell
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AstraZeneca
Disclaimer: Curated by HT Syndication....